Royal Prince Alfred Hospital, proudly supported by Central and Eastern Sydney PHN, are holding a face-to-face session on non-invasive prenatal screening presented by Professor John Hyett, Head of High Risk Obstetrics and a Senior Staff Specialist in Obstetrics and Maternal and Fetal Medicine at Royal Prince Alfred Hospital.

Non-invasive prenatal screening through analysis of cell free DNA first became available in Australia in 2013 and is now widely used, particularly in the private healthcare sector.

There is now a significant body of evidence that confirms that this is the most efficacious screening test for Down syndrome as well as other common forms of aneuploidy.

The range of applications of NIPT has continued to develop and the test can now be applied to twin pregnancies and has been shown to be effective in detecting conditions such as triploidy and deletion 22q11.2

A series of cases will be discussed that show the value of NIPT and demonstrate how it is best embedded in clinical management. Developments, such as genome wide NIPT and screening for rare autosomal trisomies that are likely of little diagnostic value and have the potential to reduce overall efficacy of this screening test will also be discussed.

Key Learning Points

• Effectiveness of NIPT and its role in screening for adverse pregnancy outcomes
• Advances in screening in twins
• Reduction of ‘no-call’ rates and recognition of trisomy 13 and triploidy
• Beware the test that ‘does everything’ – does it? and is there added value or risk of harm? 

Please note you will need to self-report your attendance this activity to the RACGP or other governing body.

Proudly sponsored by Natera.

2 ANSC Points have been allocated for this event.

Target audience: GPs

*Please note GP Registrars who wish to register for CPD events and do not have a member number will need to contact the CPD Department on 1300 986 991